TET2 and lymphoma: Consistent with the observation that patients with TET2 mutated lymphomas harbor the same mutation in their HSC (125), the contribution of these alterations to lymphomagenesis was studied in vivo by engineering the conditional loss of Tet2 in HSCs or at later stages of B-cell development (126).